These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 15364949)
1. Arrestin regulates MAPK activation and prevents NADPH oxidase-dependent death of cells expressing CXCR2. Zhao M; Wimmer A; Trieu K; Discipio RG; Schraufstatter IU J Biol Chem; 2004 Nov; 279(47):49259-67. PubMed ID: 15364949 [TBL] [Abstract][Full Text] [Related]
2. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323 [TBL] [Abstract][Full Text] [Related]
3. Modulation of vascular smooth muscle cell alignment by cyclic strain is dependent on reactive oxygen species and P38 mitogen-activated protein kinase. Chen Q; Li W; Quan Z; Sumpio BE J Vasc Surg; 2003 Mar; 37(3):660-8. PubMed ID: 12618707 [TBL] [Abstract][Full Text] [Related]
4. Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation. Gesty-Palmer D; Chen M; Reiter E; Ahn S; Nelson CD; Wang S; Eckhardt AE; Cowan CL; Spurney RF; Luttrell LM; Lefkowitz RJ J Biol Chem; 2006 Apr; 281(16):10856-64. PubMed ID: 16492667 [TBL] [Abstract][Full Text] [Related]
5. Beta-arrestin mediates desensitization and internalization but does not affect dephosphorylation of the thyrotropin-releasing hormone receptor. Jones BW; Hinkle PM J Biol Chem; 2005 Nov; 280(46):38346-54. PubMed ID: 16183993 [TBL] [Abstract][Full Text] [Related]
6. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression. Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936 [TBL] [Abstract][Full Text] [Related]
7. Palmitoylation of the V2 vasopressin receptor carboxyl tail enhances beta-arrestin recruitment leading to efficient receptor endocytosis and ERK1/2 activation. Charest PG; Bouvier M J Biol Chem; 2003 Oct; 278(42):41541-51. PubMed ID: 12900404 [TBL] [Abstract][Full Text] [Related]
8. A novel protein kinase A-independent, beta-arrestin-1-dependent signaling pathway for p38 mitogen-activated protein kinase activation by beta2-adrenergic receptors. Gong K; Li Z; Xu M; Du J; Lv Z; Zhang Y J Biol Chem; 2008 Oct; 283(43):29028-36. PubMed ID: 18678875 [TBL] [Abstract][Full Text] [Related]
9. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis. Gripentrog JM; Miettinen HM Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804 [TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor-induced clathrin-mediated endocytosis requires beta-arrestin-1 recruitment and activation of the p38 MAPK signalosome at the plasma membrane for actin bundle formation. McLaughlin NJ; Banerjee A; Kelher MR; Gamboni-Robertson F; Hamiel C; Sheppard FR; Moore EE; Silliman CC J Immunol; 2006 Jun; 176(11):7039-50. PubMed ID: 16709866 [TBL] [Abstract][Full Text] [Related]
11. beta-Arrestin 2 expression determines the transcriptional response to lysophosphatidic acid stimulation in murine embryo fibroblasts. Gesty-Palmer D; El Shewy H; Kohout TA; Luttrell LM J Biol Chem; 2005 Sep; 280(37):32157-67. PubMed ID: 16027114 [TBL] [Abstract][Full Text] [Related]
12. Galpha12/13-mediated production of reactive oxygen species is critical for angiotensin receptor-induced NFAT activation in cardiac fibroblasts. Fujii T; Onohara N; Maruyama Y; Tanabe S; Kobayashi H; Fukutomi M; Nagamatsu Y; Nishihara N; Inoue R; Sumimoto H; Shibasaki F; Nagao T; Nishida M; Kurose H J Biol Chem; 2005 Jun; 280(24):23041-7. PubMed ID: 15826947 [TBL] [Abstract][Full Text] [Related]
13. The effect of arrestin conformation on the recruitment of c-Raf1, MEK1, and ERK1/2 activation. Coffa S; Breitman M; Hanson SM; Callaway K; Kook S; Dalby KN; Gurevich VV PLoS One; 2011; 6(12):e28723. PubMed ID: 22174878 [TBL] [Abstract][Full Text] [Related]
14. beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. DeFea KA; Zalevsky J; Thoma MS; Déry O; Mullins RD; Bunnett NW J Cell Biol; 2000 Mar; 148(6):1267-81. PubMed ID: 10725339 [TBL] [Abstract][Full Text] [Related]
16. A beta-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis. Ge L; Ly Y; Hollenberg M; DeFea K J Biol Chem; 2003 Sep; 278(36):34418-26. PubMed ID: 12821670 [TBL] [Abstract][Full Text] [Related]
17. Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2. Wei H; Ahn S; Barnes WG; Lefkowitz RJ J Biol Chem; 2004 Nov; 279(46):48255-61. PubMed ID: 15355986 [TBL] [Abstract][Full Text] [Related]
18. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Luttrell LM; Ferguson SS; Daaka Y; Miller WE; Maudsley S; Della Rocca GJ; Lin F; Kawakatsu H; Owada K; Luttrell DK; Caron MG; Lefkowitz RJ Science; 1999 Jan; 283(5402):655-61. PubMed ID: 9924018 [TBL] [Abstract][Full Text] [Related]
19. Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2. Ge L; Shenoy SK; Lefkowitz RJ; DeFea K J Biol Chem; 2004 Dec; 279(53):55419-24. PubMed ID: 15489220 [TBL] [Abstract][Full Text] [Related]
20. Roles of reactive oxygen species in angiopoietin-1/tie-2 receptor signaling. Harfouche R; Malak NA; Brandes RP; Karsan A; Irani K; Hussain SN FASEB J; 2005 Oct; 19(12):1728-30. PubMed ID: 16049136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]